demonstrated that the levels of PTEN are downregulated in individuals with diabetes, and that suppression of miR-152-3p can elevate PTEN levels, thereby improving ECs functions critical to angiogenesis (100). This evidence concerns the gene PTEN and diabetes mellitus.